北方药学
北方藥學
북방약학
JOURNAL OF NORTH PHARMACY
2015年
6期
19-19
,共1页
甲氨蝶呤%米非司酮%异位妊娠%临床效果
甲氨蝶呤%米非司酮%異位妊娠%臨床效果
갑안접령%미비사동%이위임신%림상효과
Methotrexate%Mifepristone%Ectopic pregnancy%Clinical effect
目的:探讨甲氨蝶呤联合米非司酮治疗异位妊娠的临床效果。方法:选取我院收治的异位妊娠患者76例,按照治疗方式分为对照组和观察组,每组38例。对照组使用甲氨蝶呤进行治疗,观察组在对照组治疗的基础上加用米非司酮进行治疗,观察治疗后血β-HCG情况和包块的直径,比较两组治疗的总有效率。结果:经过治疗后,对照组治疗的总有效率为78.95%;观察组治疗的总有效率为97.37%,两组比较差异显著(P<0.05)。观察组在血β-HCG情况和包块直径方面的优势更加明显。结论:异位妊娠治疗过程中,采用甲氨蝶呤联合米非司酮的效果更佳,不良反应少。
目的:探討甲氨蝶呤聯閤米非司酮治療異位妊娠的臨床效果。方法:選取我院收治的異位妊娠患者76例,按照治療方式分為對照組和觀察組,每組38例。對照組使用甲氨蝶呤進行治療,觀察組在對照組治療的基礎上加用米非司酮進行治療,觀察治療後血β-HCG情況和包塊的直徑,比較兩組治療的總有效率。結果:經過治療後,對照組治療的總有效率為78.95%;觀察組治療的總有效率為97.37%,兩組比較差異顯著(P<0.05)。觀察組在血β-HCG情況和包塊直徑方麵的優勢更加明顯。結論:異位妊娠治療過程中,採用甲氨蝶呤聯閤米非司酮的效果更佳,不良反應少。
목적:탐토갑안접령연합미비사동치료이위임신적림상효과。방법:선취아원수치적이위임신환자76례,안조치료방식분위대조조화관찰조,매조38례。대조조사용갑안접령진행치료,관찰조재대조조치료적기출상가용미비사동진행치료,관찰치료후혈β-HCG정황화포괴적직경,비교량조치료적총유효솔。결과:경과치료후,대조조치료적총유효솔위78.95%;관찰조치료적총유효솔위97.37%,량조비교차이현저(P<0.05)。관찰조재혈β-HCG정황화포괴직경방면적우세경가명현。결론:이위임신치료과정중,채용갑안접령연합미비사동적효과경가,불량반응소。
Objective: To investig ate the clinical effect analysis of treatment of ectopic pregnancy with methotrexate and mifepristone. Methods: Ectopic pregnancy in our hospital were selected in 76 patients, according to the different treatment for the control group and the observation group, 38 cases in each group of patients. Patients in the control group using methotrexate treatment, patients in the observation group was treated with mifepristone plus based on the treatment in control group after treatment, observation of serum beta-HCG and mass diameter, total efficiency were compared between the two groups of treatment. Results: after treatment, the patients in the control group the total effective rate of treatment was 78.95%;the patients in the observation group were treated with a total effective rate of 97.37%, P < 0.05, with significant differences and statistical significance. More obvious in serum beta -HCG and mass diameter advantage. Conclusion:the treatment of ectopic pregnancy by methotrexate combined with mifepristone in the process, this way a better therapeutic effect, adverse reaction incidence less.